[The efficacy of Capoten in different clinical courses of acute myocardial infarct].
作者信息
Mikashinovich Z I, Terent'ev V P, Shlyk S V, Suroedova R A, Shepelev A A
出版信息
Anesteziol Reanimatol. 1996 Sep-Oct(5):39-44.
PMID:9027252
Abstract
摘要
相似文献
1
[The efficacy of Capoten in different clinical courses of acute myocardial infarct].
Anesteziol Reanimatol. 1996 Sep-Oct(5):39-44.
2
[The hemodynamic effect of Capoten in patients with myocardial infarct complicated by heart failure].
Vrach Delo. 1989 Nov(11):44-7.
3
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).缬沙坦、卡托普利或二者联用对急性心肌梗死后动脉粥样硬化事件的影响：急性心肌梗死缬沙坦试验（VALIANT）分析
J Am Coll Cardiol. 2006 Feb 21;47(4):726-33. doi: 10.1016/j.jacc.2005.09.055. Epub 2006 Jan 26.
4
5
[The antianginal activity of angiotensin-converting enzyme inhibitors].[血管紧张素转换酶抑制剂的抗心绞痛活性]
Lik Sprava. 1997 Sep-Oct(5):50-3.
6
[When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].心肌梗死后若仍存在泵功能衰竭。血管紧张素转换酶抑制剂和血管紧张素Ⅱ1型受体阻滞剂效果相当。
MMW Fortschr Med. 2003 Dec 4;145(49):18-9.
7
8
[Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].[心力衰竭中的价值再次得到证实。血管紧张素 II 阻滞剂很快也将用于心肌梗死后患者？]
MMW Fortschr Med. 2003 Oct 23;145(43):51.
9
[New options against undertreatment].
MMW Fortschr Med. 2003 Dec 4;145(49):18.
Zotero 插件